AU3642795A - Endothelin receptor antagonists for the treatment of emesis - Google Patents
Endothelin receptor antagonists for the treatment of emesisInfo
- Publication number
- AU3642795A AU3642795A AU36427/95A AU3642795A AU3642795A AU 3642795 A AU3642795 A AU 3642795A AU 36427/95 A AU36427/95 A AU 36427/95A AU 3642795 A AU3642795 A AU 3642795A AU 3642795 A AU3642795 A AU 3642795A
- Authority
- AU
- Australia
- Prior art keywords
- emesis
- treatment
- receptor antagonists
- endothelin receptor
- endothelin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31349594A | 1994-09-27 | 1994-09-27 | |
| US313495 | 1994-09-27 | ||
| PCT/US1995/012329 WO1996009818A1 (en) | 1994-09-27 | 1995-09-22 | Endothelin receptor antagonists for the treatment of emesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3642795A true AU3642795A (en) | 1996-04-19 |
Family
ID=23215928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU36427/95A Abandoned AU3642795A (en) | 1994-09-27 | 1995-09-22 | Endothelin receptor antagonists for the treatment of emesis |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3642795A (en) |
| WO (1) | WO1996009818A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19530032A1 (en) * | 1995-08-16 | 1997-02-20 | Merck Patent Gmbh | Endothelin receptor antagonists |
| US6110963A (en) * | 1998-05-12 | 2000-08-29 | American Home Products Corporation | Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6232322B1 (en) | 1998-05-12 | 2001-05-15 | American Home Products Corporation | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6221902B1 (en) | 1998-05-12 | 2001-04-24 | American Home Products Corporation | Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6166069A (en) * | 1998-05-12 | 2000-12-26 | American Home Products Corporation | Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6451827B2 (en) | 1998-05-12 | 2002-09-17 | Wyeth | 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| AU4072799A (en) | 1998-05-12 | 1999-12-13 | American Home Products Corporation | 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| US6699896B1 (en) | 1998-05-12 | 2004-03-02 | Wyeth | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6017918A (en) * | 1998-08-06 | 2000-01-25 | Warner-Lambert Company | Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
| US6284795B1 (en) | 1998-09-04 | 2001-09-04 | Warner-Lambert Company | Sulfonamide compounds and methods of treating atherosclerosis and restenosis |
| US6310081B1 (en) | 1999-05-10 | 2001-10-30 | American Home Products Corporation | Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| WO2001091736A2 (en) * | 2000-05-31 | 2001-12-06 | Warner-Lambert Company | Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
| DE60144284D1 (en) | 2000-11-01 | 2011-05-05 | Millennium Pharm Inc | NITROGENIC HETEROCYCLIC COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| EP1366012A4 (en) | 2001-02-09 | 2005-11-02 | Merck & Co Inc | 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| AR037097A1 (en) | 2001-10-05 | 2004-10-20 | Novartis Ag | ACILSULFONAMID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT |
| US7176322B2 (en) | 2002-05-23 | 2007-02-13 | Amgen Inc. | Calcium receptor modulating agents |
| US6908935B2 (en) | 2002-05-23 | 2005-06-21 | Amgen Inc. | Calcium receptor modulating agents |
| GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
| GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
| EP2590951B1 (en) | 2010-07-09 | 2015-01-07 | Pfizer Limited | Benzenesulfonamides useful as sodium channel inhibitors |
| WO2012007868A2 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
| WO2012007861A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| EP2593433B1 (en) | 2010-07-12 | 2014-11-26 | Pfizer Limited | N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels |
| US9102621B2 (en) | 2010-07-12 | 2015-08-11 | Pfizer Limited | Acyl sulfonamide compounds |
| CA2804877A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain |
| BR112013016033A2 (en) | 2010-12-23 | 2018-06-05 | Pfizer | glucagon receptor modulators |
| ES2597972T3 (en) | 2011-02-08 | 2017-01-24 | Pfizer Inc | Glucagon receptor modulator |
| ES2550345T3 (en) | 2011-07-22 | 2015-11-06 | Pfizer Inc. | Quinolinylglucagon receptor modulators |
| US9085517B2 (en) | 2011-12-15 | 2015-07-21 | Pfizer Limited | Sulfonamide derivatives |
| TW201811766A (en) | 2016-08-29 | 2018-04-01 | 瑞士商諾華公司 | N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease |
| WO2021118826A1 (en) * | 2019-12-12 | 2021-06-17 | Daljit Dhanoa | Deuterium-enriched substituted phenoxyphenyl acetic acids and acylsulfonamides |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5334598A (en) * | 1993-03-19 | 1994-08-02 | Merck & Co., Inc. | Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives |
-
1995
- 1995-09-22 AU AU36427/95A patent/AU3642795A/en not_active Abandoned
- 1995-09-22 WO PCT/US1995/012329 patent/WO1996009818A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996009818A1 (en) | 1996-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3642795A (en) | Endothelin receptor antagonists for the treatment of emesis | |
| AU5873594A (en) | Endothelin receptor antagonists | |
| AU7692996A (en) | Receptor antagonists | |
| AU4030695A (en) | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis | |
| AU2143295A (en) | Neurokinin receptor antagonists | |
| AU6810596A (en) | Substituted biphenylsulfonamide endothelin antagonists | |
| AU4803996A (en) | Endothelin receptor antagonists | |
| EP0763035A4 (en) | Endothelin receptor antagonists | |
| AU3665793A (en) | Fibrinogen receptor antagonists | |
| AU1441695A (en) | Fibrinogen receptor antagonists | |
| AU4679793A (en) | Endothelin receptor antagonists | |
| AU3953795A (en) | Bicyclic neuropeptide y receptor antagonists | |
| HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
| AU8374491A (en) | Angiotensin II receptor antagonists | |
| AU7694496A (en) | Endothelin receptor antagonists | |
| HU9600256D0 (en) | Substituted diphenyl-sulfonamides, antagonists of endothelin | |
| AU1230795A (en) | Adhesion receptor antagonists | |
| AU6856796A (en) | Des-arg9-bk antagonists | |
| AU7528696A (en) | Muscarine antagonists | |
| EP0766684A4 (en) | Endothelin receptor antagonists | |
| AU5322994A (en) | Fibrinogen receptor antagonists | |
| AU3661895A (en) | Adhesion receptor antagonists | |
| AU7478496A (en) | Muscarine antagonists | |
| AU6764596A (en) | Endothelin receptor antagonists | |
| AU6060796A (en) | Endothelin receptor antagonists |